NTN3 and neuroblastoma: Further exploitation of dependence receptor stimulation for cancer cell killing is undertaken by targeting Netrin-3, an understudied member of the Netrin ligand family in cancer, whose expression correlates with cancer aggressiveness in neuroblastoma and small cell lung cancer (SCLC) (Gibert team).